This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: The Clinic for Special Children, University of Massachusetts. Active years: 2025-2026.
Company Filing History:
2 out of 3 
2 out of 1,625 
Years Active: 2025-2026
Title: Kevin A Strauss: Innovator in Gene Therapy for Maple Syrup Urine Disease
Introduction
Kevin A Strauss is a notable inventor based in Strasburg, PA (US). He has made significant contributions to the field of gene therapy, particularly in addressing rare metabolic disorders. His work focuses on innovative solutions that aim to improve the quality of life for individuals affected by these conditions.
Latest Patents
Kevin A Strauss holds 1 patent related to AAV-mediated gene therapy for Maple Syrup Urine Disease (MSUD). This patent provides compositions and methods for promoting the expression of functional BCKDHA and BCKDHB proteins, which are essential components of the branched-chain alpha-keto acid dehydrogenase complex. The methods outlined in his patent offer potential treatments for subjects suffering from MSUD, a serious metabolic disorder.
Career Highlights
Throughout his career, Kevin has worked with esteemed institutions such as the University of Massachusetts and The Clinic for Special Children. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kevin A Strauss has collaborated with notable professionals, including Guangping Gao and Dan Wang. These partnerships have furthered his research and development efforts in gene therapy.
Conclusion
Kevin A Strauss is a pioneering inventor whose work in gene therapy has the potential to transform the treatment of Maple Syrup Urine Disease. His innovative approaches and collaborations highlight the importance of research in addressing rare metabolic disorders.